World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
33041
World Ranking
1303
National Ranking
49

Medicine

D-Index
85
Citations
33207
World Ranking
14445
National Ranking
478

Paul J. Hertzog publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul J. Hertzog sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 348 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul J. Hertzog D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul J. Hertzog sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul J. Hertzog is affiliated with the Hudson Institute of Medical Research in Australia. Their body of work primarily spans the fields of Immunology and Microbiology as well as Medicine, with a focus on several subfields including Immunology, Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, and Molecular Biology.

The research topics covered by Paul J. Hertzog include:

  • Immune Cell Function and Interaction
  • Interferon and Immune Responses
  • T-cell and B-cell Immunology
  • Cytokine Signaling Pathways and Interactions
  • Immunotherapy and Immune Responses
  • Immune Cells in Cancer
  • Immune Response and Inflammation

Their recent published papers demonstrate a wide scope of study within these domains. Notable publications include:

  • "Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages," 2021, Nature Communications
  • "Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone," 2020, EMBO Reports
  • "Interferon-ε is a tumour suppressor and restricts ovarian cancer," 2023, Nature
  • "Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses," 2021, Journal of Extracellular Vesicles
  • "Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing," 2022, American Journal of Respiratory and Critical Care Medicine

Paul J. Hertzog has collaborated frequently with several co-authors, with the most frequent including:

  • Linden J. Gearing
  • Nicole A. de Weerd
  • Antony Y. Matthews
  • Michelle D. Tate
  • San Sui Lim

Their work has appeared in multiple venues, most commonly:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • PLoS Pathogens
  • SSRN Electronic Journal
  • Cell Reports

Best Publications

  • Interferon-γ: an overview of signals, mechanisms and functions

    Kate Schroder;Paul John Hertzog;Timothy Ravasi;David A Hume

  • INTERFEROME v2.0: an updated database of annotated interferon-regulated genes

    Irina Rusinova;Samuel Forster;Simon Xiaoming Yu;Anitha Kannan

  • SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine

    Warren S Alexander;Robyn Starr;Robyn Starr;Jennifer E Fenner;Clare L Scott;Clare L Scott

  • Antitumour actions of interferons: implications for cancer therapy

    Belinda S. Parker;Jai Rautela;Jai Rautela;Jai Rautela;Paul J. Hertzog

  • Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells

    Thomas Luft;Ken C Pang;Elisabeth Thomas;Paul J Hertzog

  • Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.

    Hubertus Hochrein;Ken Shortman;David Vremec;Bernadette M Scott

  • Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

    Ashley Scott Mansell;Rosealee Anne Smith;Sarah L Doyle;Pearl Gray

  • Mice with a Homozygous Null Mutation for the Most Abundant Glutathione Peroxidase, Gpx1, Show Increased Susceptibility to the Oxidative Stress-inducing Agents Paraquat and Hydrogen Peroxide

    Judy Bettina De Haan;Cecile Bladier;Peter Griffiths;Michael J Kelner

  • Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.

    Maxine Gowen;Francesca Lazner;Robert Dodds;Rasesh Kapadia

  • The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

    Elizabeth C. Carroll;Lei Jin;Andres Mori;Natalia Muñoz-Wolf

  • Mouse Plasmacytoid Cells Long-lived Cells, Heterogeneous in Surface Phenotype and Function, that Differentiate Into CD8+ Dendritic Cells Only after Microbial Stimulus

    Meredith O’Keeffe;Hubertus Hochrein;David Vremec;Irina Caminschi

  • A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses

    Seung Y. Hwang;Paul J. Hertzog;Kerry A. Holland;Sony H. Sumarsono

  • Type I Interferon Receptors: Biochemistry and Biological Functions

    Nicole Anne De Weerd;Shamith Samarajiwa;Paul John Hertzog

  • Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

    Bradley N Bidwell;Bradley N Bidwell;Clare Y Slaney;Clare Y Slaney;Nimali P Withana;Nimali P Withana;Sam Forster

  • Analysis of microRNA turnover in mammalian cells following Dicer1 ablation

    Michael P. Gantier;Claire E. McCoy;Irina Rusinova;Damien Saulep

  • Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells

    Maria Kaparakis;Lynne Turnbull;Leticia Carneiro;Stephen Firth

  • STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice

    Matthias Ernst;Meri Najdovska;Dianne Grail;Therese Lundgren-May

  • Type I IFN contributes to NK cell homeostasis, activation, and antitumor function.

    Jeremy B Swann;Yashihiro Hayakawa;Nadeen Zerafa;Kathleen Cf Sheehan

  • IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.

    HyeonJoo Cheon;Elise Holvey-Bates;John W Schoggins;Samuel Forster

  • GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on Type I interferon signaling

    Andrew J Fleetwood;Andrew J Fleetwood;Hang Dinh;Hang Dinh;Andrew D Cook;Andrew D Cook;Paul John Hertzog;Paul John Hertzog

  • Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

    Jennifer Eve Fenner;Robyn J Starr;Ann L Cornish;Ann L Cornish;Jian-Guo Zhang

Frequent Co-Authors

Ismail Kola
Ismail Kola MSD (United States)
Ashley Mansell
Ashley Mansell Hudson Institute of Medical Research
Anthony W. Linnane
Anthony W. Linnane Monash University
Jamie Rossjohn
Jamie Rossjohn Monash University
John A. Hamilton
John A. Hamilton University of Melbourne
Brendan J. Jenkins
Brendan J. Jenkins Hudson Institute of Medical Research
Ernst J. Wolvetang
Ernst J. Wolvetang University of Queensland
Robin L. Anderson
Robin L. Anderson La Trobe University
Johnson Mak
Johnson Mak Griffith University
Meredith O'Keeffe
Meredith O'Keeffe Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career pathways. Many professionals start with foundational programs like the best online BSN programs for non nurses, which offer accessible entry points for individuals transitioning into nursing and healthcare fields.

Once equipped with a nursing background, accelerating your education through an accelerated FNP program can fast-track your path to becoming a Family Nurse Practitioner (FNP), providing broader clinical experience and opportunities to work in immunology-related settings.

For FNPs seeking to specialize further, obtaining an acute care certification for FNP is a strategic step to move into acute care environments, enhancing expertise in managing complex immunological conditions and critical care patients.

Financial considerations are also important when planning your career. Understanding how much do DNPs make can help set realistic salary expectations and guide your investment in education based on location and specialization.

Best Scientists Citing Paul J. Hertzog

Trending Scientists

Recently Published Articles